ADENOSINE INJECTION

The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC a firm-fixed-price delivery order under basic contract SPE2DX25D9900 for the procurement of 6 packages of ADENOSINE INJECTION, identified by NSN 6505016660343 and NDC 25021-0301-68, at a total contract value of $1,388.70. The delivery is scheduled for July 21, 2026, with FOB Destination terms requiring the contractor to bear all transportation costs and risks until delivery at Joint Base Elmendorf-Richardson in Alaska. The contractor is certified as a small business, small disadvantaged business, and women-owned business, and invoicing must comply with DFARS 252.232-7003, submitted via the designated payment office in Columbus, Ohio. The contract includes no options, quantity variances, or flexibility in fulfillment, representing a single-line-item transaction with no future funding anticipated. The item is procured for government use, with inspection and acceptance conducted by the government at the delivery point, based on conformance to contractual requirements. While the contract references the contractor’s CAGE code 1UNB0 and DLA’s CAGE 4RP13, along with the NSN and NDC for identification, no specific packaging, preservation, labeling, or barcoding standards are detailed, and no MIL-STDs or technical specifications are incorporated. The contracting officer is Lisa Quinn, with Shairy M. Cartagena serving as a local administrative contact, and no certified contracting officer representative is named. The procurement falls under NAICS 424210 and was issued as an award notice without formal evaluation factors or section-specific clauses detailed in the documentation, relying primarily on administrative data and the governing base contract for terms.